De novo review is a type of administrative process used to evaluate the safety and efficacy of medical products. It involves experts from multiple disciplines, such as medicine, chemistry, engineering, pharmacology and toxicology. The purpose of de novo review is to ensure that the product meets regulatory requirements before it can be marketed or sold in a jurisdiction.
In terms of cryptocurrency regulation specifically, de novo reviews are conducted by financial regulators who have established their own set rules for digital assets transactions – including those related to cryptocurrencies like Bitcoin and Ethereum – in order to protect investors and prevent frauds or scams. As part of this process, these authorities examine every aspect related with an asset’s use-case: its technology (blockchain), voting system (governance model) supply mechanics (inflation levels) among others factors depending on each case individually. De novo reviews may also require additional information from developers about how they will handle customer service matters or other legal issues associated with blockchain technology usage .
Overall, the goal behind conducting a de novo review for cryptocurrency projects is twofold: firstly, it helps determine whether all applicable regulations are followed; secondly – it provides assurance that any given project adheres highest standards when guaranteeing investor protection via transparent reporting processes while at same time promoting innovation within crypto space overall.
